We wish you well during this difficult time and we welcome you to review Medicom’s summary of the American Heart Association’s Virtual Scientific Sessions 2020. As we have come to expect this year, this rich exchange of science and clinical updates was conducted through an interactive virtual platform. In the following pages, you will find a summary of the cutting edge and late-breaking science that was presented including new updates in COVID 19, new results of a polypill approach, advances in heart failure, advances in vascular medicine, and many clinical trial results and key sub-analyses.
A key focus of this year’s sessions were efforts to focus on groups and patients who are often underrepresented in cardiovascular research, including women, children, ethnic minorities, and the elderly, and you will find summaries in this report. Disparities in healthcare and research remain a serious problem globally and we support the commitment to work as a ...
Please login to read the full text of the article.
If you have no account yet, please register now.
« Dapagliflozin could rapidly curb worsening heart failure, death Next Article
MRI-based test promising for mass prostate-cancer screening »